Mark J. DiNubile

17.8k total citations · 4 hit papers
160 papers, 9.2k citations indexed

About

Mark J. DiNubile is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Mark J. DiNubile has authored 160 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Infectious Diseases, 67 papers in Epidemiology and 23 papers in Hepatology. Recurrent topics in Mark J. DiNubile's work include HIV/AIDS drug development and treatment (23 papers), HIV Research and Treatment (20 papers) and Antifungal resistance and susceptibility (18 papers). Mark J. DiNubile is often cited by papers focused on HIV/AIDS drug development and treatment (23 papers), HIV Research and Treatment (20 papers) and Antifungal resistance and susceptibility (18 papers). Mark J. DiNubile collaborates with scholars based in United States, Germany and Spain. Mark J. DiNubile's co-authors include Carole A. Sable, K. Rajender Reddy, Savino Bruno, Ira M. Jacobson, Clifford A. Brass, Janice K. Albrecht, Navdeep Boparai, Mark Sulkowski, Bruce R. Bacon and Fred Poordad and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Mark J. DiNubile

159 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

2011 1.9k citations Mark J. DiNubile et al. profile →
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

2009 478 citations Jeffrey L. Lennox, Edwin DeJesus et al. profile →
Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection

2015 386 citations Deborah D. Brown, Mark J. DiNubile et al. profile →
Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience

2016 341 citations Mark J. DiNubile, Alfred J. Saah et al. Clinical Infectious Diseases profile →

Peers

Countries citing papers authored by Mark J. DiNubile

Since Specialization

Citations

This map shows the geographic impact of Mark J. DiNubile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. DiNubile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. DiNubile more than expected).

Fields of papers citing papers by Mark J. DiNubile

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. DiNubile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. DiNubile. The network helps show where Mark J. DiNubile may publish in the future.

Co-authorship network of co-authors of Mark J. DiNubile

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. DiNubile. A scholar is included among the top collaborators of Mark J. DiNubile based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. DiNubile. Mark J. DiNubile is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Low HDL-c levels at admission are associated with greater severity and worse clinical outcomes in patients with COVID-19 disease 2023 ·SHILAP Revista de lepidopterología ·Sandra Parra, Mireia Saballs, Mark J. DiNubile, M. Feliu, Simona Iftimie, (unknown), (unknown), Alba Ávila, Susan L. Levinson, Antoni Castro	7
2	Blood-Borne Microparticles Are an Inflammatory Stimulus in Type 2 Diabetes Mellitus 2023 ·ImmunoHorizons ·Stephen R. Thom, Veena M. Bhopale, Awadhesh K. Arya, (unknown), Abid Bhat, Nandita Mitra, Ole Hoffstad, D. Scot Malay, (unknown), John C Lantis, Hadar Lev‐Tov, Robert S. Kirsner, Ru‐ching Hsia, Susan L. Levinson, Mark J. DiNubile, David J. Margolis	9
3	Association of plasma gelsolin with frailty phenotype and mortality among octogenarian community-dwelling men: a cohort study 2022 ·Aging Clinical and Experimental Research ·Timo Strandberg, Susan L. Levinson, Mark J. DiNubile, Satu K. Jyväkorpi, Mika Kivimäki	1
4	Emergence of resistance-associated variants after failed triple therapy with vaniprevir in treatment-experienced non-cirrhotic patients with hepatitis C-genotype 1 infection: A population and clonal analysis 2013 ·Virology ·Richard J. O. Barnard, Carolyn McHale, (unknown), (unknown), Donald J. Graham, (unknown), Julie Strizki, Peggy Hwang, (unknown), Jacqueline D. Reeves, David C. Nickle, Mark J. DiNubile, Daria J. Hazuda, Niloufar Mobashery	18
5	Transesophageal Echocardiograms in Patients with Catheter-derived Staphylococcus aureus Bacteremia 2012 ·The American Journal of Medicine ·Mark J. DiNubile	2
6	Unexpectedly high burden of rotavirus gastroenteritis in very young infants 2010 ·BMC Pediatrics ·H. F. Clark, (unknown), (unknown), (unknown), Mark J. DiNubile	16
7	Raltegravir Versus Efavirenz Regimens in Treatment-Naive HIV-1–Infected Patients: 96-Week Efficacy, Durability, Subgroup, Safety, and Metabolic Analyses 2010 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Jeffrey L. Lennox, Edwin DeJesus, Daniel S Berger, Adriano Lazzarin, Richard B. Pollard, José Valdez Madruga, Jing Zhao, Hong Wan, Christopher L. Gilbert, Hedy Teppler, Anthony Rodgers, Richard J. O. Barnard, Michael D. Miller, Mark J. DiNubile, Bach-Yen Nguyen, Randi Y. Leavitt, Peter Sklar	194
8	Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort 2010 ·European Journal of Clinical Microbiology & Infectious Diseases ·J. Hiemenz, Issam Raad, J. Maertens, Ray Hachem, Alfred J. Saah, Carole A. Sable, J Chodakewitz, (unknown), Patricia Saddier, Russell S. Berman, Desmon̄d Ryan, Mark J. DiNubile, Thomas F. Patterson, David W. Denning, Thomas J. Walsh	32
9	Decline in Rotavirus (RV) Gastroenteritis (GE) Presenting to The Children’s Hospital of Philadelphia (CHOP) After Introduction of Pentavalent Rotavirus Vaccine (PRV). 2008 ·46th Annual Meeting ·Mark J. DiNubile	0
10	HIV Seroconversion without Infection after Receipt of Adenovirus‐Vectored HIV Type 1 Vaccine 2008 ·Clinical Infectious Diseases ·Erin Quirk, Robin Mogg, Deborah D. Brown, Michelle Lally, Devan V. Mehrotra, Mark J. DiNubile, Michael Robertson	15
11	Bowel colonization with vancomycin-resistant enterococci after antimicrobial therapy for intra-abdominal infections: observations from 2 randomized comparative clinical trials of ertapenem therapy 2007 ·Diagnostic Microbiology and Infectious Disease ·Mark J. DiNubile, Ian R. Friedland, Christina Y. Chan, Mary Motyl, Hilde Giezek, Kathleen McCarroll, (unknown), John P. Quinn, Robert A. Weinstein, Joseph W. Chow	9
12	In Vitro Susceptibilities of Escherichia coli Isolated from Patients with Intra-Abdominal Infections Worldwide in 2002–2004: Results from SMART (Study for Monitoring Antimicrobial Resistance Trends) 2006 ·Surgical Infections ·Grant V. Bochicchio, Fernando Baquero, Po‐Ren Hsueh, David L. Paterson, Flávia Rossi, (unknown), Kathleen McCarroll, Vilas Satishchandran, Mark J. DiNubile, Joseph W. Chow	24
13	Erectile Dysfunction in an Urban HIV-Positive Population 2006 ·AIDS Patient Care and STDs ·Alexander R. Ende, Vincent Lo Re, Mark J. DiNubile, Karam Mounzer	38
14	In Vitro Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli Isolated from Patients with Intra- Abdominal Infections Worldwide: The 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART) 2005 ·Surgical Infections ·Joseph W. Chow, Vilas Satishchandran, (unknown), Charlotte M. Harvey, Ian R. Friedland, Mark J. DiNubile	52
15	Invasive candidiasis in cancer patients: observations from a randomized clinical trial 2005 ·Journal of Infection ·Mark J. DiNubile, Darcy A. Hille, Carole A. Sable, Nicholas A. Kartsonis	41
16	Ertapenem versus ceftriaxone and metronidazole as treatment for complicated intra-abdominal infections 2005 ·International Journal of Surgery ·(unknown), (unknown), (unknown), (unknown), Frank J. Branicki, Junmin Wei, (unknown), France Vrijens, Hilde Giezek, Christina Y. Chan, Mark J. DiNubile	14
17	Incidence of Myocardial Infarction in Randomized Clinical Trials of Protease Inhibitor-Based Antiretroviral Therapy: An Analysis of Four Different Protease Inhibitors 2003 ·AIDS Research and Human Retroviruses ·Paul Coplan, Alexander Nikas, Anthony J. Japour, (unknown), Hilal Maradit Kremers, (unknown), Yi Xu, Mark J. DiNubile	50
18	Response and Relapse Rates of Candidal Esophagitis in HIV-Infected Patients Treated with Caspofungin 2002 ·AIDS Research and Human Retroviruses ·Mark J. DiNubile, Robert Lupinacci, Rayanne S. Berman, Carole A. Sable	27
19	Amphotericin B lipid complex in pediatric patients with invasive fungal infections 1999 ·The Pediatric Infectious Disease Journal ·Thomas J. Walsh, Nita L. Seibel, Carola Arndt, Richard E. Harris, Mark J. DiNubile, Annette C. Reboli, John Hiemenz, Stephen J. Chanock	97
20	Relationship of Admission Plasma Gelsolin Levels to Clinical Outcomes in Patients after Major Trauma 1999 ·American Journal of Respiratory and Critical Care Medicine ·Karam Mounzer, Michael Moncure, (unknown), Mark J. DiNubile	86

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact